Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
UBS
US Department of Justice
Chinese Patent Office
Fish and Richardson
AstraZeneca
QuintilesIMS
Johnson and Johnson
Federal Trade Commission

Generated: September 23, 2018

DrugPatentWatch Database Preview

Colestipol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for colestipol hydrochloride and what is the scope of colestipol hydrochloride patent protection?

Colestipol hydrochloride is the generic ingredient in three branded drugs marketed by Pharmacia Upjohn and Impax Labs, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for colestipol hydrochloride. Four suppliers are listed for this compound.

Pharmacology for colestipol hydrochloride
Medical Subject Heading (MeSH) Categories for colestipol hydrochloride
Synonyms for colestipol hydrochloride
37296-80-3
AC1MJ2ZS
C11H28ClN5O.HCl
C60H114O8.HCl
Cholestabyl
Colestid
Colestipol HCl
Colestipol hydrochloride [USAN:USP]
Colestipol hydrochloride [USAN]
Copolymer of diethylenetriamine and 1-chloro-2,3-epoxypropane, hydrochloride (with approximately 1 out of 5 amine nitrogens protonated)
D0GJ8R
DTXSID40190737
Flavored Colestid
FT-0749664
GACQNVJDWUAPFY-UHFFFAOYSA-N
Lestid
LS-54700
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine hydrochloride
SCHEMBL284758
tetraethylenepentamine HCl
U-26597A
UNII-X7D10K905G
X7D10K905G

US Patents and Regulatory Information for colestipol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs COLESTIPOL HYDROCHLORIDE colestipol hydrochloride TABLET;ORAL 077510-001 Oct 24, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-003 Sep 22, 1995 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for colestipol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
UBS
US Department of Justice
Chinese Patent Office
Fish and Richardson
AstraZeneca
QuintilesIMS
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.